Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Krishnan Suma

Over the trailing 90 days, Krishnan Suma (Director at Krystal Biotech, Inc.) sold $7.7M of stock in KRYS, per 11 SEC Form 4 transactions.

Role
Director
Companies
KRYS
Window
Trailing 90 days · 11 transactions · CIK 1298711
Net activity
−$7.7M ($0 bought · $7.7M sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
KRYSKrystal Biotech, Inc.11$7.7M−$7.7M

Transactions (11)

DateSymbolTypeSharesValueDescription
2026-06-04KRYSSell480$147KOpen market or private sale
2026-06-04KRYSSell240$75KOpen market or private sale
2026-06-04KRYSSell2.0K$634KOpen market or private sale
2026-06-04KRYSSell2.8K$868KOpen market or private sale
2026-06-04KRYSSell3.8K$1.2MOpen market or private sale
2026-06-04KRYSSell12.7K$3.9MOpen market or private sale
2026-06-04KRYSSell1.3K$414KOpen market or private sale
2026-06-04KRYSSell320$96KOpen market or private sale
2026-06-04KRYSSell593$179KOpen market or private sale
2026-06-04KRYSSell247$75KOpen market or private sale
2026-06-04KRYSSell400$122KOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Krishnan's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free